<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The rate of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> before surgery of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is 11% in Japan </plain></SENT>
<SENT sid="1" pm="."><plain>The survival rate of radical surgery with D-3 lymph node adenectomy is 83.7% in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and 77.1% in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The percentage of recurrent <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> after curative surgery with D-3 lymph node extent resection is 7.1% within 5 years </plain></SENT>
<SENT sid="3" pm="."><plain>Hepatectomy has the best survival rate: 52.8% after 3 years, 39.2% after 5 years </plain></SENT>
<SENT sid="4" pm="."><plain>There is no difference in patients' survival rate between systemic anatomical hepatectomy and non-anatomical limited resection </plain></SENT>
<SENT sid="5" pm="."><plain>For recurrent <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastasis</z:e> after curative surgery, hepatectomy should be done if no other <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is found in any other organ and the patient is suitable for surgery </plain></SENT>
<SENT sid="6" pm="."><plain>Hepatic artery infusion chemotherapy (HAI) for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of the liver is no longer used today </plain></SENT>
<SENT sid="7" pm="."><plain>Radiofrequency ablation or microwave coagulation therapy may prolong the survival time but is not a curative procedure </plain></SENT>
</text></document>